PARTNERS

Bionanotechnology and drug delivery systems have extensive potential to address several problems that cannot be solved using conventional strategies.

APL is working with several partners across the globe including government organizations, research institutes, and pharmaceutical companies with complementary expertise in disease biology to drive our development pipeline forward.